Results 171 to 180 of about 110,625 (292)
WHO classification of skin tumours: key updates in the fifth edition
This review article summarizes the key updates in the 5th edition of the WHO Classification of Skin Tumours. It provides an overview of the major changes and new entities specific to the skin section, covering areas such as epidermal, melanocytic, mesenchymal and other tumours. The 5th edition of the World Health Organization Classification of Tumours (
Gabrielle Goldman‐Lévy +29 more
wiley +1 more source
Langerhans cell histiocytosis manifesting at birth: a neonatal case with BRAF V600E mutation. [PDF]
Tang W, Wang P.
europepmc +1 more source
Radiological conference. Langerhans' cell histiocytosis
Acw Chin, Wcg Peh
openalex +1 more source
Rapid resolution of primary vulval adult Langerhans cell histiocytosis with very potent topical corticosteroids [PDF]
Susan M. Foley +4 more
openalex +1 more source
A death from Langerhans cell histiocytosis and tuberculosis in 18th Century Hungary - what palaeopathology can tell us today [PDF]
Donoghue, HD, Pap, I, Spigelman, M
core
We evaluated the diagnostic utility of GPNMB immunohistochemistry in LAM. GPNMB showed strong expression in LAM cells, while the differential diagnostic mimics showed no or only low expression. Based on its 100% sensitivity and specificity in our cohort, GPNMB is a highly reliable immunohistochemical marker for the diagnosis of LAM.
Fatime Szalai +6 more
wiley +1 more source
Treating metastatic extraocular retinoblastoma complicated with Langerhans cell histiocytosis. [PDF]
Hameed M +4 more
europepmc +1 more source
ABSTRACT Mesenchymal stromal cells (MSCs) exert their effects primarily through paracrine signaling via soluble factors and extracellular vesicles (EVs), especially exosomes. These acellular components offer regenerative and immunomodulatory benefits with fewer safety and logistical constraints than cell‐based therapies.
Marcela da Costa Pereira Cestari +2 more
wiley +1 more source

